D-838-2013 Class I Terminated
FDA drug recall D-838-2013 was initiated by Zydus Pharmaceuticals USA Inc on May 13, 2013 and is designated Class I. Reason for recall: Failed Tablet/Capsule Specifications: A product complaint was received from a pharmacist who discovered that 3 tablets in a 1000-count bottle were oversized. The recall status is terminated (terminated May 5, 2015). Affected quantity: 960 Bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 14, 2013
- Initiation Date
- May 13, 2013
- Termination Date
- May 5, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 960 Bottles
Product description
Warfarin Sodium Tablets, USP 2 mg, Rx Only, 1000 Tablets per bottle, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534, NDC 68382-053-10
Reason for recall
Failed Tablet/Capsule Specifications: A product complaint was received from a pharmacist who discovered that 3 tablets in a 1000-count bottle were oversized.
Distribution pattern
Nationwide
Code information
Lot MM5767
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-838-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026